Oklahoma City-based COARE Biotechnology awarded $220K grant

Local firm has received a grant to help develop a treatment for pancreatic cancer.

Published: Thursday, August 29, 2013 By: Staff Reports Source: The Oklahoman

Oklahoma City-based COARE Biotechnology Inc. has been awarded a $220,099 grant by the National Institutes of Health to develop a new treatment for pancreatic cancer.

COARE Biotechnology was founded in 2010 by Dr. Courtney Houchen to advance a promising new treatment for pancreatic cancer.

Houchen is a professor of medicine, the chief of digestive diseases and nutrition in the Department of Medicine at the University of Oklahoma, a member of the Peggy and Charles Stephenson Cancer Center and chief medical adviser of the company.